American Association for the Study of Liver Diseases and Latin American Association for the Study of the Liver Joint Symposium: Challenges in Drug-Induced Liver Injury, a Tale of Two Continents

Description

The America Association for the Study of Liver Diseases and the Latin American Association for the Study of the Liver joint symposium focuses on the experiences of investigators in Latin America and the United States with hepatotoxicity due to drugs and herbal and dietary supplements (HDSs). The first part of the session focuses on the epidemiology, prevalence, and increasing incidence of hepatotoxicity due to HDSs. Given increasing HDS use and availability (including online), presenters stress the importance of learning about new compounds, trends in HDS use, and potential new toxins for all hepatologists and other health care professionals practicing in the field to be aware of. The second portion of the symposium focuses on drug-induced autoimmune-like hepatitis (DI-ALH), a clinical challenge in many cases of hepatotoxicity. In this segment, experts discuss the presentation, diagnosis, and management of DI-ALH, and how to differentiate it from de novo autoimmune hepatitis.